GlassScriptPhysician profile
Whitney R Ceretti
NPI 1376945568
$2,625.85
in general payments reported to CMS, 2019-2025
18 companies · $789 in 2025
The $789 reported for 2025 was more than what 79% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $81.56 · 2022: $57.20 · 2023: $85.97 · 2024: $1,612 · 2025: $789.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,047 · Food and Beverage: $1,040 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,047.22 |
| Food and Beverage | $1,039.87 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $400.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,403.62 | 2024 | |
| Senseonics, Incorporated | $400.00 | 2025 | Eversense |
| Abbott Laboratories | $159.22 | 2023-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Beta Bionics, INC. | $115.80 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Sequel Med Tech, LLC | $113.80 | 2025 | Twiist |
| Abbvie INC. | $72.48 | 2021-2023 | |
| Ascensia Diabetes Care US INC. | $55.13 | 2024-2025 | |
| Medtronic, INC. | $52.88 | 2024-2025 | Minimed 780g |
| Insulet Corporation | $43.73 | 2024 | Omnipod |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $35.35 | 2022-2023 | Xifaxan, Trulance |
| Novo Nordisk INC | $30.06 | 2024 | Ozempic, Rybelsus |
| Pfizer INC. | $27.34 | 2022 | |
| Lilly USA, LLC | $25.75 | 2022-2025 | Zepbound, Mounjaro |
| Hologic Sales and Service, LLC | $19.27 | 2024 | Aptima, Thinprep 2000 Processor |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $19.00 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $18.59 | 2021 | |
| Sanofi-Aventis U.S. LLC | $17.66 | 2025 | |
| Dexcom, INC. | $16.17 | 2023 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Whitney Ceretti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.